In this system, the 5-HTT is well known as the target of action of serotonin reuptake inhibiters, agents in the treatment of many neuropsychiatric disorders (e.g. PTSD, depression, anxiety disorders, etc.). This evidence concerns the gene SLC6A4 and depressive symptom measurement.